21.961 articles found

Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan.

Fox SH, Henry B, Hill MP, Peggs D, Crossman AR, Brotchie JM.

Mov Disord · 2001-07-01

DOI: 10.1002/mds.1148PMID: 11481687

Chronic levodopa therapy does not improve skilled reach accuracy or reach range on a pasta matrix reaching task in 6-OHDA dopamine-depleted (hemi-Parkinson analogue) rats.

Metz GA, Farr T, Ballermann M, Whishaw IQ.

Eur J Neurosci · 2001-07-01

DOI: 10.1046/j.0953-816x.2001.01615.xPMID: 11488946

Successful treatment of excessive daytime sleepiness in Parkinson's disease with modafinil.

Happe S, Pirker W, Sauter C, Klösch G, Zeitlhofer J.

J Neurol · 2001-07-01

DOI: 10.1007/s004150170148PMID: 11518012

Cost-effectiveness of pergolide compared to bromocriptine in the treatment of Parkinson's disease: a decision-analytic model.

Davey P, Rajan N, Lees M, Aristides M.

Value Health · 2001-07-01

DOI: 10.1046/j.1524-4733.2001.44039.xPMID: 11705298

Embryonic mesencephalic transplantation for the treatment of advanced Parkinson's disease.

Check source for author details

Tecnologica MAP Suppl · 2001-07-01

PMID: 11718150

The effectiveness of occupational therapy-related treatments for persons with Parkinson's disease: a meta-analytic review.

Murphy S, Tickle-Degnen L.

Am J Occup Ther · 2001-07-01

DOI: 10.5014/ajot.55.4.385PMID: 11723982

Parkinson's disease: the treatment of drug-induced hallucinations and psychosis.

Molho ES, Factor SA.

Curr Neurol Neurosci Rep · 2001-07-01

DOI: 10.1007/s11910-001-0085-8PMID: 11898537

Initial treatment of early Parkinson's disease: a review of recent, randomized controlled trials.

Biglan K, Holloway RG.

Curr Neurol Neurosci Rep · 2001-07-01

DOI: 10.1007/s11910-001-0086-7PMID: 11898538

Adenosine/dopamine interaction: implications for the treatment of Parkinson's disease.

Ferré S, Popoli P, Giménez-Llort L, Rimondini R, Müller CE, Strömberg I, Ögren SO, Fuxe K.

Parkinsonism Relat Disord · 2001-07-01

DOI: 10.1016/s1353-8020(00)00063-8PMID: 11331192

Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition

FLESHNER-BARAK MOSHE, LERNER E. ITZHAK, ROSENBERGER VERED, DAHAN MAZAL, MAKOV YISRAEL.

· 2001-06-22

Therapeutic combinations of fatty acids

HORROBIN DAVID FREDERICK.

· 2001-06-20

Exo-S-mecamylamine formulation and use in treatment

SHYTLE DOUGLAS, SANBERG PAUL, NEWMAN MARY, SILVER ARCHIE A.

· 2001-06-15